These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 2566681
1. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists. Galitzky J, Mauriege P, Berlan M, Lafontan M. J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681 [Abstract] [Full Text] [Related]
2. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine. Taouis M, Berlan M, Lafontan M. Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286 [Abstract] [Full Text] [Related]
3. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Turner JT, Ray-Prenger C, Bylund DB. Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671 [Abstract] [Full Text] [Related]
4. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location. Taouis M, Berlan M, Montastruc P, Lafontan M. J Pharmacol Exp Ther; 1987 Sep; 242(3):1041-9. PubMed ID: 2821223 [Abstract] [Full Text] [Related]
5. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304. Galitzky J, Lafontan M, Paris H, Berlan M. J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682 [Abstract] [Full Text] [Related]
6. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding. Paris H, Galitzky J, Senard JM. Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632 [Abstract] [Full Text] [Related]
7. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462. Saulnier-Blache JS, Taouis M, Dauzats M, Uzan A, Berlan M, Lafontan M. J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742 [Abstract] [Full Text] [Related]
8. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites. Langin D, Paris H, Lafontan M. Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775 [Abstract] [Full Text] [Related]
14. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. Murphy TJ, Bylund DB. J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455 [Abstract] [Full Text] [Related]
15. [Evidence for an alpha 2-blocking property of nicergoline by using antilipolytic alpha-adrenoceptors from adipose tissue]. Carpéné C, Lafontan M, Berlan M. J Pharmacol; 1983 Feb; 14(1):57-66. PubMed ID: 6132024 [Abstract] [Full Text] [Related]
16. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Neubig RR, Gantzos RD, Brasier RS. Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672 [Abstract] [Full Text] [Related]
17. Inhibition of adenylate cyclase activity in human fat cells by alpha-adrenergic agonists. Wright EE, Simpson ER. Horm Metab Res; 1982 Sep; 14(9):475-9. PubMed ID: 6128294 [Abstract] [Full Text] [Related]